| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating | 
|---|---|---|---|---|---|---|
| Shell | 0.82% | $85.31M | $218.67B | 15.00% | 73 Outperform | |
| Roche Holding AG | 0.75% | $77.50M | CHF208.68B | 3.87% | 73 Outperform | |
| ASML Holding | 0.73% | $75.38M | $407.86B | 47.17% | 81 Outperform | |
| HSBC Holdings | 0.69% | $71.30M | $243.82B | 51.50% | 78 Outperform | |
| Novartis | 0.65% | $67.71M | $234.55B | 11.67% | 73 Outperform | |
| Rheinmetall | 0.63% | $65.77M | €79.42B | 260.07% | 60 Neutral | |
| SAFRAN SA | 0.60% | $62.17M | €126.53B | 45.69% | 67 Neutral | |
| Celestica | 0.59% | $61.45M | $38.96B | 366.62% | 73 Outperform | |
| Toyota Motor | 0.55% | $57.24M | $268.82B | 20.56% | 70 Outperform | |
| UBS Group AG | 0.51% | $53.15M | $122.05B | 19.10% | ― |